Parameters of the spectral analysis of the heart rate variability in treating depression

Medicina (Kaunas). 2009;45(3):214-20.

Abstract

The objective of this work was to study circadian rhythms of the indicators of the spectral analysis of the heart rate variability in case of depression.

Materials and methods: A total of 37 patients, with a mean age of 46.7+/-10.3 years, were examined. According to the International Classification of Disease, 10th revision (ICD-10), endogenous depression was diagnosed for all of them (F 31.3-31.4, F 32.0-32.2, F 33.0-33.2). To assess the variability of the heart rhythm, the spectral analysis was used. The patients were examined at 1 AM, 7 AM, 1 PM, 7 PM prior to the beginning of treatment, following one week, and upon leaving the inpatient department. The control group consisted of 15 mentally healthy people.

Results: Before the beginning of treatment, desynchronization of circadian rhythms of the indicators studied and the sleep-wake cycle, the increase in the spectrum power within low-frequency (LF) range, and the decrease in the spectrum power within high-frequency (HF) range were observed. Reduction of depression symptoms was followed by resynchronization of the rhythms under study, with a spectrum power within LF range being increased and that within HF range--decreased.

Conclusions: Changes in depression symptoms and chronobiological disorders testify to their close pathogenetic link.

Publication types

  • Comparative Study
  • Evaluation Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antidepressive Agents, Second-Generation / therapeutic use
  • Circadian Rhythm*
  • Citalopram / therapeutic use
  • Depressive Disorder / diagnosis
  • Depressive Disorder / drug therapy
  • Depressive Disorder / physiopathology*
  • Electrocardiography
  • Female
  • Heart Rate / physiology*
  • Humans
  • Inpatients
  • Male
  • Middle Aged
  • Signal Processing, Computer-Assisted
  • Sleep Stages
  • Spectrum Analysis
  • Statistics, Nonparametric
  • Time Factors

Substances

  • Antidepressive Agents, Second-Generation
  • Citalopram